Your browser doesn't support javascript.
loading
A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine.
Hankaniemi, Minna M; Stone, Virginia M; Sioofy-Khojine, Amir-Babak; Heinimäki, Suvi; Marjomäki, Varpu; Hyöty, Heikki; Blazevic, Vesna; Laitinen, Olli H; Flodström-Tullberg, Malin; Hytönen, Vesa P.
Afiliação
  • Hankaniemi MM; Faculty of Medicine and Health Technology, Tampere University, FI-33014 Tampere, Finland.
  • Stone VM; Faculty of Medicine and Health Technology, Tampere University, FI-33014 Tampere, Finland; The Center for Infectious Medicine, Karolinska Institutet, Department of Medicine Huddinge, Karolinska University Hospital, Alfred Nobels Allé 8, SE-14152 Stockholm, Sweden.
  • Sioofy-Khojine AB; Faculty of Medicine and Health Technology, Tampere University, FI-33014 Tampere, Finland.
  • Heinimäki S; Vaccine Research Center, Faculty of Medicine and Health Technology, Tampere University, FI-33014 Tampere, Finland.
  • Marjomäki V; Department of Biological and Environmental Science/Nanoscience Center, University of Jyväskylä, P.O. Box 35, FI-40014 University of Jyväskylä, Finland.
  • Hyöty H; Faculty of Medicine and Health Technology, Tampere University, FI-33014 Tampere, Finland; Fimlab Laboratories, Pirkanmaa Hospital District, FI-33520 Tampere, Finland.
  • Blazevic V; Vaccine Research Center, Faculty of Medicine and Health Technology, Tampere University, FI-33014 Tampere, Finland.
  • Laitinen OH; Faculty of Medicine and Health Technology, Tampere University, FI-33014 Tampere, Finland.
  • Flodström-Tullberg M; Faculty of Medicine and Health Technology, Tampere University, FI-33014 Tampere, Finland; The Center for Infectious Medicine, Karolinska Institutet, Department of Medicine Huddinge, Karolinska University Hospital, Alfred Nobels Allé 8, SE-14152 Stockholm, Sweden.
  • Hytönen VP; Faculty of Medicine and Health Technology, Tampere University, FI-33014 Tampere, Finland; Fimlab Laboratories, Pirkanmaa Hospital District, FI-33520 Tampere, Finland. Electronic address: vesa.hytonen@tuni.fi.
Vaccine ; 37(40): 5962-5971, 2019 09 20.
Article em En | MEDLINE | ID: mdl-31471148
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Enterovirus Humano B / Infecções por Coxsackievirus / Imunogenicidade da Vacina Tipo de estudo: Guideline Limite: Animals Idioma: En Revista: Vaccine Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Enterovirus Humano B / Infecções por Coxsackievirus / Imunogenicidade da Vacina Tipo de estudo: Guideline Limite: Animals Idioma: En Revista: Vaccine Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Finlândia